Divi's Laboratories · NSE: DIVISLAB · BSE: 532488
Q1 FY25 results · Apr–Jun 2024
Divi's Laboratories reported revenue from operations of ₹2,118.00 crore (up 19.1% from Q1 FY24) and net profit of ₹430.00 crore (up 20.8% from Q1 FY24) for Q1 FY25 (Apr–Jun 2024), on a consolidated basis.
| Item | Q1 FY25 | Q1 FY24 | YoY | Q4 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 2,118.00 | 1,778.00 | +19.1% | 2,303.00 | −8.0% |
| Other income | 79.00 | 81.00 | −2.5% | 79.00 | +0.0% |
| Total income | 2,197.00 | 1,859.00 | +18.2% | 2,382.00 | −7.8% |
| Profit before tax | 604.00 | 492.00 | +22.8% | 713.00 | −15.3% |
| Net profit for the period | 430.00 | 356.00 | +20.8% | 538.00 | −20.1% |
| EPS, basic (₹) | 16.20 | 13.41 | +20.8% | 20.25 | −20.0% |
| Net margin (%) | 20.3 | 20.0 | 23.4 |
| Item | Q1 FY25 | Q1 FY24 | YoY | Q4 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 2,063.00 | 1,730.00 | +19.2% | 2,259.00 | −8.7% |
| Other income | 79.00 | 80.00 | −1.2% | 79.00 | +0.0% |
| Total income | 2,142.00 | 1,810.00 | +18.3% | 2,338.00 | −8.4% |
| Profit before tax | 603.00 | 478.00 | +26.2% | 700.00 | −13.9% |
| Net profit for the period | 430.00 | 345.00 | +24.6% | 531.00 | −19.0% |
| EPS, basic (₹) | 16.18 | 12.99 | +24.6% | 19.99 | −19.1% |
| Net margin (%) | 20.8 | 19.9 | 23.5 |
Consolidated
- Filed with BSE
- 05 Aug 2024, 13:13 IST
- Board meeting
- 03 Aug 2024
- Period
- 01 Apr 2024 to 30 Jun 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 05 Aug 2024, 13:13 IST
- Board meeting
- 03 Aug 2024
- Period
- 01 Apr 2024 to 30 Jun 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE